JP2022531898A5 - - Google Patents
Info
- Publication number
- JP2022531898A5 JP2022531898A5 JP2021566160A JP2021566160A JP2022531898A5 JP 2022531898 A5 JP2022531898 A5 JP 2022531898A5 JP 2021566160 A JP2021566160 A JP 2021566160A JP 2021566160 A JP2021566160 A JP 2021566160A JP 2022531898 A5 JP2022531898 A5 JP 2022531898A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305593 | 2019-05-09 | ||
| EP19305593.6 | 2019-05-09 | ||
| EP19305679.3 | 2019-05-28 | ||
| EP19305679 | 2019-05-28 | ||
| US201962945311P | 2019-12-09 | 2019-12-09 | |
| US62/945,311 | 2019-12-09 | ||
| PCT/EP2020/062743 WO2020225375A1 (en) | 2019-05-09 | 2020-05-07 | 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid for use in metastatic or advanced breast cancer patients |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531898A JP2022531898A (ja) | 2022-07-12 |
| JPWO2020225375A5 JPWO2020225375A5 (https=) | 2023-05-01 |
| JP2022531898A5 true JP2022531898A5 (https=) | 2023-05-01 |
Family
ID=70681807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566160A Ceased JP2022531898A (ja) | 2019-05-09 | 2020-05-07 | 転移性または進行性乳房がん患者において使用するための６－（２，４－ジクロロフェニル）－５－［４－［（３ｓ）－１－（３－フルオロプロピル）ピロリジン－３－イル］オキシフェニル］－８，９－ジヒドロ－７ｈ－ベンゾ［７］アヌレン－２－カルボン酸 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20200352905A1 (https=) |
| EP (1) | EP3965758A1 (https=) |
| JP (1) | JP2022531898A (https=) |
| KR (1) | KR20220006553A (https=) |
| CN (1) | CN114173776A (https=) |
| AU (1) | AU2020268762A1 (https=) |
| BR (1) | BR112021022216A2 (https=) |
| CA (1) | CA3146346A1 (https=) |
| IL (1) | IL287805A (https=) |
| MX (1) | MX2021013711A (https=) |
| SG (1) | SG11202111979SA (https=) |
| TW (1) | TW202110434A (https=) |
| WO (1) | WO2020225375A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7413363B2 (ja) | 2018-09-07 | 2024-01-15 | サノフイ | メチル６－（２，４－ジクロロフェニル）－５－［４－［（３ｓ）－１－（３－フルオロプロピル）ピロリジン－３－イル］オキシフェニル］－８，９－ジヒドロ－７ｈ－ベンゾ［７］アヌレン－２－カルボキシレートの調製方法 |
| WO2021063967A1 (en) | 2019-10-01 | 2021-04-08 | Sanofi | Novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof |
| KR20220113695A (ko) | 2019-12-09 | 2022-08-16 | 사노피 | 7h-벤조[7]아눌렌-2-카르복실산 유도체의 결정질 형태 |
| TW202146007A (zh) | 2020-02-27 | 2021-12-16 | 法商賽諾菲公司 | 包含阿培利司（ａｌｐｅｌｉｓｉｂ）與６－（２，４－二氯苯基）－５－［４－［（３ｓ）－１－（３－氟丙基）吡咯啶－３－基］氧苯基］－８，９－二氫－７ｈ－苯并［７］輪烯－２－羧酸之組合 |
| WO2022084280A1 (en) | 2020-10-19 | 2022-04-28 | Sanofi | Substituted 6,7-dihydro-5h-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof |
| EP4247363A1 (en) * | 2020-11-23 | 2023-09-27 | Sanofi | Combination comprising abemaciclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
| TWI837605B (zh) * | 2021-03-09 | 2024-04-01 | 美商美國禮來大藥廠 | 使用serd組合給藥方案治療癌症之方法 |
| CN117042771A (zh) * | 2021-03-09 | 2023-11-10 | 伊莱利利公司 | 使用serd给药方案的组合治疗癌症的方法 |
| TW202400136A (zh) * | 2022-03-13 | 2024-01-01 | 法商賽諾菲公司 | 以安森司群(amcenestrant)治療乳癌 |
| TW202543650A (zh) | 2024-03-08 | 2025-11-16 | 美商海爾達醫療運營公司 | 異雙官能化合物及其在治療疾病中之用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19833786A1 (de) * | 1998-07-18 | 2000-01-20 | Schering Ag | Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| WO2015082990A1 (en) * | 2013-12-06 | 2015-06-11 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer |
| JP7019422B2 (ja) * | 2015-04-29 | 2022-02-15 | ラジウス ファーマシューティカルズ，インコーポレイテッド | 癌を治療するための方法 |
| SMT202300018T1 (it) * | 2015-12-09 | 2023-03-17 | Univ Illinois | Downregolatori del recettore degli estrogeni a base di benzotiofene |
| LT3416962T (lt) * | 2016-02-15 | 2021-07-12 | Sanofi | 6,7-dihidro-5h-benzo[7]anuleno dariniai kaip estrogenų recepptoriaus moduliatoriai |
| EP3434272A1 (en) * | 2017-07-25 | 2019-01-30 | Sanofi | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
-
2020
- 2020-05-07 BR BR112021022216A patent/BR112021022216A2/pt not_active IP Right Cessation
- 2020-05-07 MX MX2021013711A patent/MX2021013711A/es unknown
- 2020-05-07 EP EP20725471.5A patent/EP3965758A1/en not_active Withdrawn
- 2020-05-07 AU AU2020268762A patent/AU2020268762A1/en not_active Abandoned
- 2020-05-07 KR KR1020217038971A patent/KR20220006553A/ko not_active Ceased
- 2020-05-07 SG SG11202111979SA patent/SG11202111979SA/en unknown
- 2020-05-07 WO PCT/EP2020/062743 patent/WO2020225375A1/en not_active Ceased
- 2020-05-07 CN CN202080048052.XA patent/CN114173776A/zh active Pending
- 2020-05-07 CA CA3146346A patent/CA3146346A1/en active Pending
- 2020-05-07 JP JP2021566160A patent/JP2022531898A/ja not_active Ceased
- 2020-05-08 TW TW109115366A patent/TW202110434A/zh unknown
- 2020-05-08 US US16/870,031 patent/US20200352905A1/en not_active Abandoned
-
2021
- 2021-11-02 IL IL287805A patent/IL287805A/en unknown
-
2023
- 2023-09-01 US US18/241,419 patent/US20240091194A1/en not_active Abandoned